Literature DB >> 25957666

Modular vaccine packaging increases packing efficiency.

Bryan A Norman1, Jayant Rajgopal1, Jung Lim1, Katrin Gorham2, Leila Haidari3, Shawn T Brown4, Bruce Y Lee5.   

Abstract

BACKGROUND: Within a typical vaccine supply chain, vaccines are packaged into individual cylindrical vials (each containing one or more doses) that are bundled together in rectangular "inner packs" for transport via even larger groupings such as cold boxes and vaccine carriers. The variability of vaccine inner pack and vial size may hinder efficient vaccine distribution because it constrains packing of cold boxes and vaccine carriers to quantities that are often inappropriate or suboptimal in the context of country-specific vaccination guidelines.
METHODS: We developed in Microsoft Excel (Microsoft Corp., Redmond, WA) a spreadsheet model that evaluated the impact of different packing schemes for the Benin routine regimen plus the introduction of the Rotarix vaccine. Specifically, we used the model to compare the current packing scheme to that of a proposed modular packing scheme.
RESULTS: Conventional packing of a Dometic RCW25 that aims to maximize fully-immunized children (FICs) results in 123 FICs and a packing efficiency of 81.93% compared to a maximum of 155 FICs and 94.1% efficiency for an alternative modular packaging system.
CONCLUSIONS: Our analysis suggests that modular packaging systems could offer significant advantages over conventional vaccine packaging systems with respect to space efficiency and potential FICs, when they are stored in standard vaccine carrying devices. This allows for more vaccines to be stored within the same volume while also simplifying the procedures used by field workers to pack storage devices. Ultimately, modular packaging systems could be a simple way to help increase vaccine coverage worldwide.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Modular packaging; Packaging; Primary container; Supply chain; Vaccine vial; Vaccines

Mesh:

Substances:

Year:  2015        PMID: 25957666      PMCID: PMC4640929          DOI: 10.1016/j.vaccine.2015.04.091

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  A passive cold storage device economic model to evaluate selected immunization location scenarios.

Authors:  Bryan A Norman; Sevnaz Nourollahi; Sheng-I Chen; Shawn T Brown; Erin G Claypool; Diana L Connor; Michelle M Schmitz; Jayant Rajgopal; Angela R Wateska; Bruce Y Lee
Journal:  Vaccine       Date:  2013-09-07       Impact factor: 3.641

2.  How influenza vaccination policy may affect vaccine logistics.

Authors:  Tina-Marie Assi; Korngamon Rookkapan; Jayant Rajgopal; Vorasith Sornsrivichai; Shawn T Brown; Joel S Welling; Bryan A Norman; Diana L Connor; Sheng-I Chen; Rachel B Slayton; Yongjua Laosiritaworn; Angela R Wateska; Stephen R Wisniewski; Bruce Y Lee
Journal:  Vaccine       Date:  2012-04-24       Impact factor: 3.641

3.  Only adding stationary storage to vaccine supply chains may create and worsen transport bottlenecks.

Authors:  Leila A Haidari; Diana L Connor; Angela R Wateska; Shawn T Brown; Leslie E Mueller; Bryan A Norman; Michelle M Schmitz; Proma Paul; Jayant Rajgopal; Joel S Welling; Jim Leonard; Erin G Claypool; Yu-Ting Weng; Sheng-I Chen; Bruce Y Lee
Journal:  J Public Health Manag Pract       Date:  2013 Sep-Oct

4.  The benefits of redesigning Benin's vaccine supply chain.

Authors:  Shawn T Brown; Benjamin Schreiber; Brigid E Cakouros; Angela R Wateska; Hamadou M Dicko; Diana L Connor; Philippe Jaillard; Mercy Mvundura; Bryan A Norman; Carol Levin; Jayant Rajgopal; Mélanie Avella; Caroline Lebrun; Erin Claypool; Proma Paul; Bruce Y Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

5.  Determining the optimal vaccine vial size in developing countries: a Monte Carlo simulation approach.

Authors:  Aswin Dhamodharan; Ruben A Proano
Journal:  Health Care Manag Sci       Date:  2012-04-19

6.  Replacing the measles ten-dose vaccine presentation with the single-dose presentation in Thailand.

Authors:  Bruce Y Lee; Tina-Marie Assi; Korngamon Rookkapan; Diana L Connor; Jayant Rajgopal; Vorasith Sornsrivichai; Shawn T Brown; Joel S Welling; Bryan A Norman; Sheng-I Chen; Rachel R Bailey; Ann E Wiringa; Angela R Wateska; Anirban Jana; Willem G Van Panhuis; Donald S Burke
Journal:  Vaccine       Date:  2011-03-23       Impact factor: 3.641

Review 7.  Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles.

Authors:  Bruce Y Lee; Donald S Burke
Journal:  Vaccine       Date:  2009-09-25       Impact factor: 3.641

8.  Removing the regional level from the Niger vaccine supply chain.

Authors:  Tina-Marie Assi; Shawn T Brown; Souleymane Kone; Bryan A Norman; Ali Djibo; Diana L Connor; Angela R Wateska; Jayant Rajgopal; Rachel B Slayton; Bruce Y Lee
Journal:  Vaccine       Date:  2013-04-17       Impact factor: 3.641

9.  Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model.

Authors:  Tina-Marie Assi; Shawn T Brown; Ali Djibo; Bryan A Norman; Jayant Rajgopal; Joel S Welling; Sheng-I Chen; Rachel R Bailey; Souleymane Kone; Hailu Kenea; Diana L Connor; Angela R Wateska; Anirban Jana; Stephen R Wisniewski; Willem G Van Panhuis; Donald S Burke; Bruce Y Lee
Journal:  BMC Public Health       Date:  2011-06-02       Impact factor: 3.295

10.  Augmenting transport versus increasing cold storage to improve vaccine supply chains.

Authors:  Leila A Haidari; Diana L Connor; Angela R Wateska; Shawn T Brown; Leslie E Mueller; Bryan A Norman; Michelle M Schmitz; Proma Paul; Jayant Rajgopal; Joel S Welling; Jim Leonard; Sheng-I Chen; Bruce Y Lee
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.